Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Low-dose DMSO may help treat castration-resistant prostate cancer by reducing key cancer cell receptors.

Consult an oncologist before using supplements for hair loss during breast cancer treatment.

Platelet-rich fibrin may help reduce nonmelanoma skin cancer cell growth.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

Blocking LFA-1 prevents hair loss in mice.

Finasteride and dutasteride increase sexual dysfunction reports.

Photodynamic therapy is the preferred treatment for skin precancer due to its effectiveness and safety.

Spironolactone is effective and safe for treating acne with minimal side effects.

Curcumin spanlastics are the most effective for cancer therapy due to their strong antimicrobial, antioxidant, and antitumor effects.

GnRH treatment can reduce breast cancer cell invasion.

Vitexin shows promise as a cancer treatment by affecting key cellular processes and pathways.

Targeting LGR4 may help treat cancer by reducing cancer stem cell traits and drug resistance.

Aging reduces hair cell size and function in mice, contributing to hearing loss.

Dacomitinib can cause nail and skin issues, but these can be managed without stopping the drug.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Androgenetic alopecia is a long-term, immune-related disorder that starts during puberty due to androgen secretion, and it might be improved with iron tablets, platelet transfusion, and anti-inflammation therapy.

Six new genes linked to early hair loss were found, which also surprisingly connect to Parkinson's disease and lower fertility.

Six new genes linked to early hair loss were found, which also surprisingly connect to Parkinson's disease and lower fertility.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Erlotinib can cause excessive eyelash growth.

Chemotherapy reduces taste and smell, but they mostly recover after treatment; adding spices may help improve appetite.

MT-DADMe-ImmA can selectively kill head and neck cancer cells without harming normal cells.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

Targeting specific molecular pathways may improve treatments for chemoresistant cancers.

Higher BMI and lower testosterone are linked to more aggressive prostate cancer.

Cinobufacin with chemotherapy improves treatment response and quality of life in advanced breast cancer patients while reducing some side effects.

Scalp cooling effectively reduces hair loss in breast cancer patients undergoing chemotherapy.

Cannabinoids like CBD and THC may help treat non-cancer skin diseases, but more research is needed.

Inhaling medicine may reduce side effects and improve treatment for a major lung cancer type.

New CRISPR/Cas9 variants and nanotechnology-based delivery methods are improving cancer treatment, but choosing the best variant and overcoming certain limitations remain challenges.